FIELD: organic chemistry. SUBSTANCE: derivatives of triazole of the formula (I) 
and their pharmaceutically acceptable salts where R - phenyl substituted with 1-3 atoms; R1-C1-C4-alkyl; Y - F or Cl. Process is performed by reduction of compounds of the formula (II) 
where Z1 and Z2 - or a group which can be removed by reduction. Synthesized compounds were used as antimycotic agents. EFFECT: improved method of synthesis. 6 cl, 3 tbl
| Title |
Year |
Author |
Number |
| TRIAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND INTERMEDIUM COMPOUNDS |
1991 |
- Stefen Dzhems Rehj
- Kennet Richardson
|
RU2114838C1 |
| 1,2,4-TRIAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND INTERMEDIATE COMPOUNDS |
1992 |
- Rodzher Piter Dikinson[Gb]
- Kennet Richardson[Gb]
|
RU2095358C1 |
| METHOD FOR PREPARING VORICONAZOLE AND ITS ANALOGUES |
2013 |
- Barrel Adam Dzhejms Masgrejv
- O'Nejl Pedrejg Meri
- Pettman Alan Dzhon
|
RU2619928C2 |
| METHOD OF SYNTHESIS OF TRIAZOLES, ULTIMATE AND INTERMEDIATE COMPOUNDS OF METHOD |
1996 |
- Majkl Batters
- Dzhuli Ehnn Kharrison
- Alan Dzhon Pettman
|
RU2156760C2 |
| METHOD OF PRODUCING VORICONAZOLE |
2008 |
- Moon Joung-Kho
- Li Moon Sub
- Joo Dzae Kho
- Kim Dzi Sook
- Kim Khan Kiong
- Choi Chang Dzu
- Chang Joung Kil
- Li Gvan Sun
|
RU2434009C1 |
| METHOD OF PRODUCING TRIAZOLE DERIVATIVES |
0 |
- Kennet Richardson
- Subramaniyan Narayanasvami
|
SU1251802A3 |
| 2-(4-HYDROXYPIPERIDINO)-1-ALKANOL DERIVATIVES AND 2-(4- HYDROXYPIPERIDINO)-1-ALKANONE DERIVATIVES |
1992 |
|
RU2065859C1 |
| 2,7-SUBSTITUTED DERIVATIVES OF OCTAHYDRO-1H-[1,2-A]-PYRAZINE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF BINDING DOPAMINE WITH DOPAMINE D RECEPTOR |
1995 |
- Kishor A. Desaj
- Ehnton F. Dzh. Fliri
- Mark A. Sehnner
|
RU2163239C2 |
| DERIVATIVES OF PYRROLO[2,3-D]PYRIMIDINES, PHARMACEUTICAL COMPOSITION, PYRROLO[2,3-D]PYRIMIDINES, DERIVATIVES OF PYRROLE |
1993 |
|
RU2124015C1 |
| METHOD FOR PRODUCING 2-(2,4-DIFLUORPHENYL)-1,3-BIS-(1H-1,2,4-TRIAZOLE-1-YL)-PROPAN-2-OL OR PHARMACEUTICALLY PERMISSIBLE SALT THEREOF |
0 |
|
SU1306474A3 |
